Clinical studies recruiting near Boise

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · St. Luke's Cancer Institute: Boise · Eli Lilly and Company · NCT07218380 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Saint Alphonsus Regional Medical Center ( Site 0067) · Merck Sharp & Dohme LLC · NCT06136559 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Saint Alphonsus Cancer Care Center-Boise · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Saint Luke's Cancer Institute - Boise · National Cancer Institute (NCI) · NCT05099003 A Long-Term Follow-Up Study of Participants Exposed to REACT
Phase N/A · Prokidney · NCT05918523 Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay
Phase N/A · Idaho Urology · Sequenom, Inc. · NCT02586389 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · St. Luke's Cancer Institute · Hoffmann-La Roche · NCT06793215 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Saint Alphonsus Cancer Care Center-Boise · Alliance for Clinical Trials in Oncology · NCT07321652 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Saint Luke's Cancer Institute - Boise · Children's Oncology Group · NCT06368817 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Saint Luke's Cancer Institute - Boise · National Cancer Institute (NCI) · NCT05691478 Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Phase 2 · St. Lukes · Giselle Sholler · NCT02559778 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Treasure Valley Medical Research · Eli Lilly and Company · NCT07415044 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Saint Alphonsus Cancer Care Center-Boise · Alliance for Clinical Trials in Oncology · NCT07091617 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Saint Luke's Cancer Institute - Boise · Children's Oncology Group · NCT04322318 An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract
Phase 3 · Paradigm Clinical Research Centers, LLC · Neuvosyn Laboratories, LLC · NCT07747103 A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
Phase 3 · Study Site · Renibus Therapeutics, Inc. · NCT07355062 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Saint Alphonsus Cancer Care Center-Boise · NRG Oncology · NCT05174169 A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate
Phase 3 · Teva Investigational Site 12156 · Teva Branded Pharmaceutical Products R&D LLC · NCT06664619 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Saint Alphonsus Cancer Care Center-Boise · Alliance for Clinical Trials in Oncology · NCT06632327 Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing
NA · St. Alphonsus Regional Medical Center · University of British Columbia · NCT04634240 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Saint Luke's Cancer Institute - Boise · Alliance for Clinical Trials in Oncology · NCT06931340 A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · Treasure Valley Medical Research · Eli Lilly and Company · NCT06338995 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · CARE Institute - Boise Kidney · Takeda · NCT06963827 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Saint Luke's Cancer Institute - Boise · Alliance for Clinical Trials in Oncology · NCT06876714 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Phase N/A · St. Luke's Regional Medical Center · Boston Scientific Corporation · NCT03664609 Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or
Phase 3 · Saint Alphonsus Cancer Care Center-Boise · Canadian Cancer Trials Group · NCT03550391 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Saint Alphonsus Cancer Care Center-Boise · National Cancer Institute (NCI) · NCT04269902 A Study to Assess Growth in Children With Idiopathic Short Stature
Phase N/A · St. Luke's Children's Endocrinology · BioMarin Pharmaceutical · NCT06309979

Look up another city

Look up another condition